Healthcare & Social Infrastructure

The Global Care Crisis: A Comparative Analysis of Caregiving Dynamics

May 21, 2026 · AXIMEDIC Inc. Research & Strategic Insights

Canada, the United States, Central Asia (Silk Road Nations), and Angola



Executive Abstract

The global care economy is undergoing a profound structural transformation. Driven by rapid demographic aging, urbanization, and a widening gap between long-term care demands and formal support systems, reliance on unpaid family caregivers has evolved from a private domestic arrangement into a major macroeconomic variable.

Across advanced industrial economies and rapidly developing nations alike, unpaid caregivers sustain the foundational layer of public health and social protection systems — often at severe cost to their own financial security, physical health, and occupational stability.

63M

US Caregivers

45% increase over the past decade — nearly 1 in 4 American adults

$522B

Annual Employer Loss

US businesses lose $522B annually to caregiving-related productivity losses

95%

Unsupported in Kazakhstan

95% of Kazakh informal caregivers receive no formal medical or social support

58.5h

Weekly — Young Uzbek Women

Women aged 18–29 in Uzbekistan spend 58.5 hours per week on unpaid care

The full comparative report is available for download below, covering caregiver demographics, time intensity, psychosocial costs, workforce disruption, corporate productivity loss, state policy responses, and strategic recommendations.

The CareBee Connection

This research directly establishes the macro-economic case for CareBee — AXIMEDIC's AI caregiver management platform. The 63 million unaddressed US family caregivers represent the largest unserved population in health technology. CareBee converts the $35,000 per-employee annual productivity leak into a quantifiable corporate asset, with Harvard data showing 72% ROI within year one of care coordination benefit deployment.



About the Author

Daniel Brody, MBA

Founder & CEO, AXIMEDIC Inc.

Daniel Brody is the CEO of AXIMEDIC Inc. and President & CTO of Axina Group Inc. With deep expertise in enterprise technology architecture, capital markets, and healthcare systems, Daniel leads AXIMEDIC's strategic vision across healthcare AI, sovereign digital infrastructure, and emerging market economics.

Connect on LinkedIn